Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) は上場企業です 金融 セクターの Shell Companies 業界で事業展開. 本社所在地は Fort Lauderdale, FL, アメリカ. 現CEOは Roger Bendelac.
DMAA を有する IPO日 2025-01-27, 2 名の正社員, に上場 NASDAQ Global Select, 時価総額 $353.27M.
Drugs Made In America Acquisition Corp. operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.
